ARMCX3 Mediates Susceptibility to Hepatic Tumorigenesis Promoted by Dietary Lipotoxicity

Mirra, Serena; Gavaldà-Navarro, Aleix; Manso, Yasmina; Higuera Urbano, Monica; Serrat, Román; Salcedo Allende, Maria Teresa; Balibrea, José M.; Minguez Rosique, Beatriz

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	Mirra, Serena
dc.contributor.author	Gavaldà-Navarro, Aleix
dc.contributor.author	Manso, Yasmina
dc.contributor.author	Higuera Urbano, Monica
dc.contributor.author	Serrat, Román
dc.contributor.author	Salcedo Allende, Maria Teresa
dc.contributor.author	Balibrea, José M.
dc.contributor.author	Minguez Rosique, Beatriz
dc.date.accessioned	2021-11-19T08:46:50Z
dc.date.available	2021-11-19T08:46:50Z
dc.date.issued	2021-03-05
dc.identifier.citation	Mirra S, Gavaldà-Navarro A, Manso Y, Higuera M, Serrat R, Salcedo MT, et al. ARMCX3 Mediates Susceptibility to Hepatic Tumorigenesis Promoted by Dietary Lipotoxicity. Cancers. 2021 Mar 5;13(5):1110.
dc.identifier.issn	2072-6694
dc.identifier.uri	https://hdl.handle.net/11351/6567
dc.description	Lipotoxicitat; Obesitat
dc.description.sponsorship	The study was supported by grant 201337-30-31-32 Fundació la Marató de TV3, grant SAF2017-85722R (Ministerio de Economia y Competitividad) to F.V., grant PID2019-106764RB-C21/ AEI/ 10.13039/501100011033 from the Spanish Ministry of Science and a collaborative grant from CIBERNED to E.S, grant PI18/00961 (Instituto de Salud Carlos III) to B.M, and the Hepacare Project grant from Fundación La Caixa to M.A.A. and C.B. F.V. and E.S. are ICREA researchers.
dc.language.iso	eng
dc.publisher	MDPI
dc.relation.ispartofseries	Cancers;13(5)
dc.rights	Attribution 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/
dc.source	Scientia
dc.subject	Fetge - Càncer - Tractament
dc.subject.mesh	Carcinoma, Hepatocellular
dc.subject.mesh	/chemically induced
dc.title	ARMCX3 Mediates Susceptibility to Hepatic Tumorigenesis Promoted by Dietary Lipotoxicity
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.3390/cancers13051110
dc.subject.decs	carcinoma hepatocelular
dc.subject.decs	/inducido químicamente
dc.relation.publishversion	https://doi.org/10.3390/cancers13051110
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[Mirra S, Manso Y, Serrat R] Department of Cell Biology, Physiology and Immunology, University of Barcelona, 08007 Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, 28029 Madrid, Spain. [Gavaldà-Navarro A] Department of Biochemistry and Molecular Biomedicine and Institute of Biomedicine, University of Barcelona, 08028 Barcelona, Spain. Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain. [Higuera M] Grup de Recerca en Malalties Hepàtiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Salcedo MT] Servei de Patologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Balibrea JM] Unitat de Cirurgia Endocrina, Metabòlica i Bariàtrica, Servei de Cirurgia General, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Mínguez B] Grup de Recerca en Malalties Hepàtiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, 28029 Madrid, Spain. Unitat del Fetge, Servei de Medicina Interna, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain
dc.identifier.pmid	33807672
dc.identifier.wos	000627947800001
dc.relation.projectid	info:eu-repo/grantAgreement/ES/PE2013-2016/SAF2017-85722-R
dc.relation.projectid	info:eu-repo/grantAgreement/ES/PE2017-2020/PID2019-106764RB-C21
dc.rights.accessrights	info:eu-repo/semantics/openAccess